ArticleEuropean heart journal. Cardiovascular pharmacotherapy2021

Inclisiran: a new milestone on the PCSK9 road to tackle cardiovascular risk.

Gaetano Santulli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.